Sandberg J K, Grufman P, Wolpert E Z, Franksson L, Chambers B J, Kärre K
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.
J Immunol. 1998 Apr 1;160(7):3163-9.
To examine possible interference patterns between immunodominant CTL Ags, we analyzed the response to mixtures of five well-characterized H-2Kb-restricted epitopes, each of which had earlier been described as immunodominant within its antigenic system. Clear patterns of dominance were observed between peptides in the mixture, with the CTL response focusing on the Sendai virus nucleoprotein 324-332 and vesicular stomatitis virus nucleoprotein 52-59 epitopes. The dominance of these epitopes correlated with high CTL availability. Subdominance of the OVA(257-264) and the MCF1233 murine leukemia virus envelope 574-581 peptides could not be explained by inferior ability to bind and stabilize MHC class I molecules. Interestingly, immunodominance was broken if the peptide mixture was pulsed on bone marrow-derived dendritic cells, a mode of immunization allowing efficient recognition of a broader set of specificities. Our results show that immunodominance is neither an absolute feature of a given epitope nor does it apply only in relation to other epitopes within the same protein, micro-organism, or cell. Novel "superdominant" hierarchies emerge in the response against multiple "dominant" epitopes. A T cell competition model to explain the data in terms of a balance influenced by CTL frequencies and available APC capacity is discussed.
为了研究免疫显性CTL抗原之间可能存在的干扰模式,我们分析了对五个特征明确的H-2Kb限制性表位混合物的反应,每个表位在其抗原系统中先前都被描述为免疫显性。在混合物中的肽之间观察到了明显的优势模式,CTL反应集中在仙台病毒核蛋白324-332和水泡性口炎病毒核蛋白52-59表位上。这些表位的优势与高CTL可用性相关。OVA(257-264)和MCF1233鼠白血病病毒包膜574-581肽的次优势不能用结合和稳定MHC I类分子的能力较差来解释。有趣的是,如果将肽混合物加载到骨髓来源的树突状细胞上,免疫显性就会被打破,这种免疫方式能够有效识别更广泛的特异性。我们的结果表明,免疫显性既不是给定表位的绝对特征,也不仅仅适用于同一蛋白质、微生物或细胞内的其他表位。在针对多个“显性”表位的反应中出现了新的“超显性”层次结构。讨论了一个T细胞竞争模型,该模型根据CTL频率和可用APC能力影响的平衡来解释数据。